Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03744819 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biomarkers for Prediction of Tumor Response to Radiotherapy

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 6, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Nov 30, 2021 to Nov 30, 2025 Completion date: Nov 30, 2023 to Nov 30, 2026v4 Show 1 more changeShow less
    • Completion date: Nov 30, 2023 to Nov 30, 2026
  2. Re-verified, no change to tracked fieldsv3
  3. Primary endpoints: 1 to 3 Eligibility criteria expanded, about 8 words · Study description expanded, about 39 wordsv2 Show 2 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Study description expanded, about 39 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to explore potential biomarkers for prediction of therapeutic outcomes in patients with solid tumors after radiotherapy
Trial Details
NCT Number NCT03744819
Lead Sponsor Chuangzhen Chen
Collaborators: University of Oxford
Conditions Solid Tumors
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov